<?xml version="1.0" encoding="UTF-8"?>
<p>A conjugate meningococcal C vaccine has been funded and provided by the Australian National Immunisation Program since 2003 for all children at the age of 12 months, which reflects the previous predominance of IMD caused by this serogroup (
 <xref rid="R6" ref-type="bibr">
  <italic>6</italic>
 </xref>,
 <xref rid="R21" ref-type="bibr">
  <italic>21</italic>
 </xref>). A meningococcal B vaccine, and several quadrivalent meningococcal A, C, W, Y (MenACWY) conjugate vaccines, are registered for use in Australia but were not part of the funded program during 2017 (
 <xref rid="R6" ref-type="bibr">
  <italic>6</italic>
 </xref>,
 <xref rid="R21" ref-type="bibr">
  <italic>21</italic>
 </xref>).
</p>
